These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


470 related items for PubMed ID: 22615115

  • 1. Atorvastatin inhibits myocardin expression in vascular smooth muscle cells.
    Li J, Jiang J, Yin H, Wang L, Tian R, Li H, Wang Z, Li D, Wang Y, Gui Y, Walsh MP, Zheng XL.
    Hypertension; 2012 Jul; 60(1):145-53. PubMed ID: 22615115
    [Abstract] [Full Text] [Related]

  • 2. 2-methoxyestradiol inhibits atorvastatin-induced rounding of human vascular smooth muscle cells.
    Yin H, Gui Y, Zheng XL.
    J Cell Physiol; 2010 Mar; 222(3):556-64. PubMed ID: 19937728
    [Abstract] [Full Text] [Related]

  • 3. Statins inhibit in vitro calcification of human vascular smooth muscle cells induced by inflammatory mediators.
    Kizu A, Shioi A, Jono S, Koyama H, Okuno Y, Nishizawa Y.
    J Cell Biochem; 2004 Nov 15; 93(5):1011-9. PubMed ID: 15389884
    [Abstract] [Full Text] [Related]

  • 4. L-type voltage-gated Ca2+ channels modulate expression of smooth muscle differentiation marker genes via a rho kinase/myocardin/SRF-dependent mechanism.
    Wamhoff BR, Bowles DK, McDonald OG, Sinha S, Somlyo AP, Somlyo AV, Owens GK.
    Circ Res; 2004 Aug 20; 95(4):406-14. PubMed ID: 15256479
    [Abstract] [Full Text] [Related]

  • 5. Fn14 is upregulated in cytokine-stimulated vascular smooth muscle cells and is expressed in human carotid atherosclerotic plaques: modulation by atorvastatin.
    Muñoz-García B, Martín-Ventura JL, Martínez E, Sánchez S, Hernández G, Ortega L, Ortiz A, Egido J, Blanco-Colio LM.
    Stroke; 2006 Aug 20; 37(8):2044-53. PubMed ID: 16809572
    [Abstract] [Full Text] [Related]

  • 6. Potential Role of Glycogen Synthase Kinase-3β in Regulation of Myocardin Activity in Human Vascular Smooth Muscle Cells.
    Zhou YX, Shi Z, Singh P, Yin H, Yu YN, Li L, Walsh MP, Gui Y, Zheng XL.
    J Cell Physiol; 2016 Feb 20; 231(2):393-402. PubMed ID: 26129946
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of serotonin-induced mitogenesis, migration, and ERK MAPK nuclear translocation in vascular smooth muscle cells by atorvastatin.
    Li M, Liu Y, Dutt P, Fanburg BL, Toksoz D.
    Am J Physiol Lung Cell Mol Physiol; 2007 Aug 20; 293(2):L463-71. PubMed ID: 17545489
    [Abstract] [Full Text] [Related]

  • 8. Statins activate GATA-6 and induce differentiated vascular smooth muscle cells.
    Wada H, Abe M, Ono K, Morimoto T, Kawamura T, Takaya T, Satoh N, Fujita M, Kita T, Shimatsu A, Hasegawa K.
    Biochem Biophys Res Commun; 2008 Oct 03; 374(4):731-6. PubMed ID: 18671946
    [Abstract] [Full Text] [Related]

  • 9. Rho Kinase Regulates Aortic Vascular Smooth Muscle Cell Stiffness Via Actin/SRF/Myocardin in Hypertension.
    Zhou N, Lee JJ, Stoll S, Ma B, Costa KD, Qiu H.
    Cell Physiol Biochem; 2017 Oct 03; 44(2):701-715. PubMed ID: 29169155
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-1 inhibits myocardin-induced contractility of human vascular smooth muscle cells.
    Jiang Y, Yin H, Zheng XL.
    J Cell Physiol; 2010 Nov 03; 225(2):506-11. PubMed ID: 20458751
    [Abstract] [Full Text] [Related]

  • 11. Use of atorvastatin to inhibit hypoxia-induced myocardin expression.
    Chiu CZ, Wang BW, Shyu KG.
    Eur J Clin Invest; 2012 May 03; 42(5):564-71. PubMed ID: 22129233
    [Abstract] [Full Text] [Related]

  • 12. Smooth muscle cell-specific transcription is regulated by nuclear localization of the myocardin-related transcription factors.
    Hinson JS, Medlin MD, Lockman K, Taylor JM, Mack CP.
    Am J Physiol Heart Circ Physiol; 2007 Feb 03; 292(2):H1170-80. PubMed ID: 16997888
    [Abstract] [Full Text] [Related]

  • 13. Atorvastatin but not elocalcitol increases sildenafil responsiveness in spontaneously hypertensive rats by regulating the RhoA/ROCK pathway.
    Fibbi B, Morelli A, Marini M, Zhang XH, Mancina R, Vignozzi L, Filippi S, Chavalmane A, Silvestrini E, Colli E, Adorini L, Vannelli GB, Maggi M.
    J Androl; 2008 Feb 03; 29(1):70-84. PubMed ID: 17699803
    [Abstract] [Full Text] [Related]

  • 14. Curcumin enhances vascular contractility via induction of myocardin in mouse smooth muscle cells.
    Sun SW, Tong WJ, Guo ZF, Tuo QH, Lei XY, Zhang CP, Liao DF, Chen JX.
    Acta Pharmacol Sin; 2017 Oct 03; 38(10):1329-1339. PubMed ID: 28504250
    [Abstract] [Full Text] [Related]

  • 15. Proteasomal degradation of myocardin is required for its transcriptional activity in vascular smooth muscle cells.
    Yin H, Jiang Y, Li H, Li J, Gui Y, Zheng XL.
    J Cell Physiol; 2011 Jul 03; 226(7):1897-906. PubMed ID: 21506120
    [Abstract] [Full Text] [Related]

  • 16. Advanced glycation end products interfere with gastric smooth muscle contractile marker expression via the AGE/RAGE/NF-κB pathway.
    Yu T, Zheng Y, Wang Y, Xiong W, Lin L.
    Exp Mol Pathol; 2017 Feb 03; 102(1):7-14. PubMed ID: 27939576
    [Abstract] [Full Text] [Related]

  • 17. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation.
    Blanco-Colio LM, Villa A, Ortego M, Hernández-Presa MA, Pascual A, Plaza JJ, Egido J.
    Atherosclerosis; 2002 Mar 03; 161(1):17-26. PubMed ID: 11882313
    [Abstract] [Full Text] [Related]

  • 18. A novel RhoA/ROCK-CPI-17-MEF2C signaling pathway regulates vascular smooth muscle cell gene expression.
    Pagiatakis C, Gordon JW, Ehyai S, McDermott JC.
    J Biol Chem; 2012 Mar 09; 287(11):8361-70. PubMed ID: 22275376
    [Abstract] [Full Text] [Related]

  • 19. HMG-CoA reductase inhibitors up-regulate anti-aging klotho mRNA via RhoA inactivation in IMCD3 cells.
    Narumiya H, Sasaki S, Kuwahara N, Irie H, Kusaba T, Kameyama H, Tamagaki K, Hatta T, Takeda K, Matsubara H.
    Cardiovasc Res; 2004 Nov 01; 64(2):331-6. PubMed ID: 15485693
    [Abstract] [Full Text] [Related]

  • 20. Atorvastatin acutely reduces the reactivity to spasmogens in rat aorta: implication of the inhibition of geranylgeranylation and MYPT-1 phosphorylation.
    Alp Yildirim Fİ, Kaleli Durman D, Aypar E, Ark M, Özdemir O, Uydeş Doğan BS.
    Fundam Clin Pharmacol; 2016 Apr 01; 30(2):96-106. PubMed ID: 26610064
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.